About
Omios Biologics develops precision therapeutics by decoding viral-host interactions using a computational platform to engineer high-potency, biomarker-driven oncolytic virus therapies targeting cancer and expanding into other disease areas.
Explore Omios Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.